| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |